Patents by Inventor Martin Hall

Martin Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190251953
    Abstract: Examples described herein provide various devices that enable users to participate in a multiplayer session. The examples allow a user that is unable to speak, or that is incapable of speaking, to participate in an in-session voice chat by inputting text and having the text converted to speech (e.g., synthesized voice data) that can then be sent to other devices participating in the session. The user enables a text-to-speech conversion feature on his or her own device. Based on the enabled feature, functionality enabling text to be entered is activated and the entered text is converted into speech data.
    Type: Application
    Filed: April 23, 2019
    Publication date: August 15, 2019
    Inventors: Jason Kepner, Evelyn R. Thomas, David Ruzyski, Jeremy L. Dewey, Martin Hall, Joshua R. McCammon, Stephen E. Giscombe, Thomas Cooper, Dana Ludwig
  • Patent number: 10343142
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: July 9, 2019
    Assignee: GE HEALTHCARE BIOPROCESS R&D AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: 10311857
    Abstract: Examples described herein provide various devices that enable users to participate in a multiplayer session. The examples allow a user that is unable to speak, or that is incapable of speaking, to participate in an in-session voice chat by inputting text and having the text converted to speech (e.g., synthesized voice data) that can then be sent to other devices participating in the session. The user enables a text-to-speech conversion feature on his or her own device. Based on the enabled feature, functionality enabling text to be entered is activated and the entered text is converted into speech data.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: June 4, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Jason Kepner, Evelyn R. Thomas, David Ruzyski, Jeremy L. Dewey, Martin Hall, Joshua R. McCammon, Stephen E. Giscombe, Thomas Cooper, Dana Ludwig
  • Publication number: 20190060869
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Application
    Filed: November 13, 2018
    Publication date: February 28, 2019
    Applicant: GE Healthcare BioProcess R&D AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: 10213765
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates to a process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: February 26, 2019
    Assignee: GE Healthcare Bioprocess R&D
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: 10179291
    Abstract: Examples described herein provide various devices that enable users to participate in a session. The examples allow a user that is unable to hear, or that is incapable of hearing, to participate in an in-session voice chat by receiving text messages that have been converted from speech to text (e.g., transcribed messages). The user enables a speech-to-text conversion feature on his or her own device. Based on the enabled feature, a notification can be sent to other devices participating in the session. Based on the notification, the other devices are tasked with capturing utterances and sending corresponding speech data to a speech-to-text conversion device so that voice communications can be converted to text messages. Subsequent to conversion, the text messages can be displayed in a chat interface presented as part of the displayed content for the session.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: January 15, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Evelyn R. Thomas, Jason Kepner, David Ruzyski, Jeremy L. Dewey, Martin Hall, Joshua R. McCammon, Kedar Hirve, Stephen E. Giscombe, Travis St. Onge, Aaron Cardwell, Matthew Labunka, Luca Beltrami, Heather Grantham Brodie
  • Publication number: 20180166065
    Abstract: Examples described herein provide various devices that enable users to participate in a multiplayer session. The examples allow a user that is unable to speak, or that is incapable of speaking, to participate in an in-session voice chat by inputting text and having the text converted to speech (e.g., synthesized voice data) that can then be sent to other devices participating in the session. The user enables a text-to-speech conversion feature on his or her own device. Based on the enabled feature, functionality enabling text to be entered is activated and the entered text is converted into speech data.
    Type: Application
    Filed: April 19, 2017
    Publication date: June 14, 2018
    Inventors: Jason Kepner, Evelyn R. Thomas, David Ruzyski, Jeremy L. Dewey, Martin Hall, Joshua R. McCammon, Stephen E. Giscombe, Thomas Cooper, Dana Ludwig
  • Publication number: 20180161683
    Abstract: Examples described herein provide various devices that enable users to participate in a session. The examples allow a user that is unable to hear, or that is incapable of hearing, to participate in an in-session voice chat by receiving text messages that have been converted from speech to text (e.g., transcribed messages). The user enables a speech-to-text conversion feature on his or her own device. Based on the enabled feature, a notification can be sent to other devices participating in the session. Based on the notification, the other devices are tasked with capturing utterances and sending corresponding speech data to a speech-to-text conversion device so that voice communications can be converted to text messages. Subsequent to conversion, the text messages can be displayed in a chat interface presented as part of the displayed content for the session.
    Type: Application
    Filed: April 19, 2017
    Publication date: June 14, 2018
    Inventors: Evelyn R. Thomas, Jason Kepner, David Ruzyski, Jeremy L. Dewey, Martin Hall, Joshua R. McCammon, Kedar Hirve, Stephen E. Giscombe, Travis St. Onge, Aaron Cardwell, Matthew Lebunka, Luca Beltrami, Heather Grantham Brodie
  • Publication number: 20180127459
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of Factor VIII and von Willebrand factor from a cryoprecipitate of plasma. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Application
    Filed: April 4, 2016
    Publication date: May 10, 2018
    Applicant: GE HEALTHCARE BIOPROCESS R&D AB
    Inventors: Martin Hall, Mikael Berg, Ida Eklind, Sandeep Kristiansson
  • Publication number: 20180127460
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of plasmaproteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Application
    Filed: April 4, 2016
    Publication date: May 10, 2018
    Applicant: GE Healthcare Bioprocess R&D AB
    Inventors: Martin Hall, Karolina Busson, Jean-Luc Maloisel, Helena Skoglar
  • Publication number: 20170259244
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIF) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 14, 2017
    Applicant: GE Healthcare BioProcess R&D AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Publication number: 20170228478
    Abstract: A method is presented for simulating marine assets (MA) in an offshore operation. The marine assets comprise at least an anchor, a line coupling the anchor with a winch, and a support platform located offshore for supporting the winch. The method involves a computation stage for estimating a state of the marine assets using a computational model and received sensor data (Ds) pertaining to a state of the marine assets and/or of an environment (ME) wherein the marine assets are used. The computational model of the marine assets (MA) includes at least a specification of an anchor, a specification of a winch and a specification of a line coupling the anchor with the winch. The at least a line is modeled as a first portion extending between the winch and a touch-down point where the line touches the seabed and a second portion extending between the touch-down point and the anchor.
    Type: Application
    Filed: February 8, 2017
    Publication date: August 10, 2017
    Applicant: Fugro N.V.
    Inventors: Keith ALEXANDER-BUCKLEY, Nicholas BRETT, Martin HALL, Jason TISDALL, Jason WILLIAMS, Richard WOOD, Scottie DOUCET
  • Patent number: 9663559
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates to a process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: May 30, 2017
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: 9652713
    Abstract: Apparatus and methods for developing parallel networks. Parallel network design may comprise a general purpose language (GPC) code portion and a network description (ND) portion. GPL tools may be utilized in designing the network. The GPL tools may be configured to produce network specification language (NSL) engine adapted to generate hardware optimized machine executable code corresponding to the network description. The developer may be enabled to describe a parameter of the network. The GPC portion may be automatically updated consistent with the network parameter value. The GPC byte code may be introspected by the NSL engine to provide the underlying source code that may be automatically reinterpreted to produce the hardware optimized machine code. The optimized machine code may be executed in parallel.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: May 16, 2017
    Assignee: QUALCOMM Technologies, Inc.
    Inventors: Jonathan James Hunt, Oleg Sinyavskiy, Robert Howard Kimball, Eric Martin Hall, Jeffrey Alexander Levin, Paul Bender, Michael-David Nakayoshi Canoy
  • Publication number: 20170047663
    Abstract: Methods, systems, and apparatus for real-time control of radio frequency (RF) reflectivity to enable radar camouflage are disclosed. A spatially diverse collection of elements, consisting of at least two elements, are used to control the direction of reradiated (reflected) energy from an object or person where direction of the reradiated energy is controlled by a circuit and a controller. The controller and circuit changes the reflectivity of each element individually as a function of time. The effect of the spatial distribution and time varying reflectors is a reflected RF signal that can statistically mimic background clutter.
    Type: Application
    Filed: August 13, 2016
    Publication date: February 16, 2017
    Inventor: George Martin Hall
  • Patent number: D769258
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: October 18, 2016
    Assignee: Microsoft Corporation
    Inventors: Martin Hall, Kelly McArthur, Andrew M. Pickard, Raymond Alexander Malkiewicz, Michael A. LaJoie, Evan Amarante Soares, Kristie E. Smith, Conroy Williamson, Sergey Kisselev
  • Patent number: D769259
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: October 18, 2016
    Assignee: Microsoft Corporation
    Inventors: Martin Hall, Kelly McArthur, Andrew M. Pickard, Raymond Alexander Malkiewicz, Michael A. LaJoie, Evan Amarante Soares, Kristie E. Smith, Conroy Williamson, Sergey Kisselev
  • Patent number: D780193
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: February 28, 2017
    Assignee: Microsoft Corporation
    Inventors: Andrew M. Pickard, Martin Hall, Raymond Alexander Malkiewicz, Michael A. LaJoie, Conroy Williamson, Sergey Kisselev
  • Patent number: D780224
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: February 28, 2017
    Assignee: Microsoft Corporation
    Inventors: Martin Hall, Raymond Alexander Malkiewicz, Michael A. LaJoie
  • Patent number: D787525
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: May 23, 2017
    Assignee: Microsoft Corporation
    Inventors: Kelly McArthur, Andrew M. Pickard, Martin Hall, Michael A. LaJoie, Evan Amarante Soares, Kristie E. Smith